Usefulness of the microbiological surveillance of respiratory syncytial virus in Galicia (Spain): 2008-2017

被引:5
作者
Servia-Dopazo, Miguel [1 ]
Jesus Purrinos-Hermida, Maria [2 ]
Perez, Sonia [3 ,4 ]
Garcia, Juan [5 ]
Malvar-Pintos, Alberto [2 ]
Trigo Daporta, Matilde [6 ]
Martinez Lamas, Lucia [3 ]
Canizares Castellanos, Angelina [7 ]
机构
[1] Complejo Hosp Univ Santiago de Compostela, Dept Med Prevent & Salud Publ, Santiago De Compostela, A Coruna, Spain
[2] Xunta Galicia, Conselleria Sanidade, Direcc Xeral Saude Publ, Serv Epidemiol, Santiago De Compostela, A Coruna, Spain
[3] Complejo Hosp Univ Vigo, Serv Microbiol, Vigo, Pontevedra, Spain
[4] Univ Vigo, Grp Enfermedades Inflamatorias & Infecciosas & Tr, Inst Invest Sanitaria Galicia Sur, Serv Galego Saude, Vigo, Pontevedra, Spain
[5] Complejo Hosp Univ Ourense, Serv Microbiol, Orense, Spain
[6] Complejo Hosp Univ Pontevedra, Serv Microbiol, Vigo, Pontevedra, Spain
[7] Complejo Hosp Univ A Coruna, Serv Microbiol, La Coruna, Spain
关键词
Respiratory syncytial virus; Microbiological surveillance system; Bronchiolitis; YOUNG-CHILDREN; INFLUENZA; RSV; HOSPITALIZATIONS; REINFECTION; INFECTIONS; MORTALITY; VACCINE; RISK;
D O I
10.1016/j.gaceta.2018.11.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To describe whether the microbiological information of the respiratory syncytial virus (RSV), provided by four hospitals on a weekly basis, adequately captures the seasonality of the RSV in the entire community. Method: Retrospective descriptive study. We compared the detection of RSV in respiratory samples of patients (hospitalized and not) from all age groups, from the 4 hospitals that are part of the microbiological surveillance system (MSS), with data from the Minimum Basic Data Set of hospitalization for bronchiolitis by RSV or another infectious organism, in patients under 5 years of age, admitted to any public hospital in Galicia (seasons 2008/2009 to 2016/2017). An epidemic wave period was considered when the positivity of RSV detections in the total respiratory samples of the SVM exceeded 10%. The sensitivity of the MSS was calculated as a percentage of admissions occurring in the epidemic wave. Results: MSS sensitivity was 92% (86%-96%) for RSV bronchiolitis admissions in each season and 79% (75%-84%) for total bronchiolitis admissions. Conclusions: The RSV microbiological surveillance system, based on data from only 4 hospitals, showed very good sensitivity to predict the start and end of the annual RSV wave throughout the Galician region. These results support the use of this information to alert the entire health system of the onset of the wave. (C) 2019 SESPAS. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:474 / 479
页数:6
相关论文
共 50 条
  • [31] Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009-2017
    Nazareno, Allen L.
    Muscatello, David J.
    Turner, Robin M.
    Wood, James G.
    Moore, Hannah C.
    Newall, Anthony T.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (06) : 1082 - 1090
  • [32] Epidemiology of Medically Attended Respiratory Syncytial Virus Lower Respiratory Tract Infection in Japanese Children, 2011-2017
    Simoes, Eric A. F.
    Botteman, Marc
    Chirikov, Viktor
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (04) : 1112 - 1122
  • [33] Epidemiology, management and costs of sepsis in Spain (2008-2017): a retrospective multicentre study
    Darba, Josep
    Marsa, Alicia
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1089 - 1095
  • [34] Validity of Laboratory-based Surveillance for Detection of Respiratory Syncytial Virus Seasons
    Hampp, Christian
    Asal, Nabih
    Lipowski, Earlene
    Kauf, Teresa
    Schneider, Eileen
    Kubilis, Paul
    Winterstein, Almut
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 (08) : 841 - 851
  • [35] Facility-based surveillance for influenza and respiratory syncytial virus in rural Zambia
    Gideon Loevinsohn
    Mutinta Hamahuwa
    Pamela Sinywimaanzi
    Katherine Z. J. Fenstermacher
    Kathryn Shaw-Saliba
    Andrew Pekosz
    Mwaka Monze
    Richard E. Rothman
    Edgar Simulundu
    Philip E. Thuma
    Catherine G. Sutcliffe
    BMC Infectious Diseases, 21
  • [36] Hospitalization cost estimates of respiratory syncytial virus and influenza infections in adults in Spain, 2016-2019
    Haeberer, M.
    De Aldecoa, A. Lopez-Ibanez
    Seabroke, S.
    Agudelo, J. L. Ramirez
    Mora, L.
    Sarabia, L.
    Peerawaranun, P.
    Meroc, E.
    Aponte-Torres, Z.
    Law, A. W.
    Sato, R.
    VACCINE, 2025, 46
  • [37] Introduction of nirsevimab in Catalonia, Spain: description of the incidence of bronchiolitis and respiratory syncytial virus in the 2023/2024 season
    Perramon-Malavez, Aida
    de Rioja, Victor Lopez
    Coma, Ermengol
    Hermosilla, Eduardo
    Fina, Francesc
    Martinez-Marcos, Montserrat
    Mendioroz, Jacobo
    Cabezas, Carmen
    Montanola-Sales, Cristina
    Prats, Clara
    Soriano-Arandes, Antoni
    EUROPEAN JOURNAL OF PEDIATRICS, 2024, 183 (12) : 5181 - 5189
  • [38] Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children
    Iwane, MK
    Edwards, KM
    Szilagyi, PG
    Walker, FJ
    Griffin, MR
    Weinberg, GA
    Coulen, C
    Poehling, KA
    Shone, LP
    Balter, S
    Hall, CB
    Erdman, DD
    Wooten, K
    Schwartz, B
    PEDIATRICS, 2004, 113 (06) : 1758 - 1764
  • [39] Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain
    Figueras-Aloy, J.
    Quero-Jimenez, J.
    Fernandez-Colomer, B.
    Guzman-Cabanas, J.
    Echaniz-Urcelay, I.
    Domenech-Martinez, E.
    ANALES DE PEDIATRIA, 2009, 71 (01): : 47 - 53
  • [40] Genomic Evolution and Surveillance of Respiratory Syncytial Virus during the 2023-2024 Season
    Yunker, Madeline
    Fall, Amary
    Norton, Julie M.
    Abdullah, Omar
    Villafuerte, David A.
    Pekosz, Andrew
    Klein, Eili
    Mostafa, Heba H.
    VIRUSES-BASEL, 2024, 16 (07):